Sleep as a Therapeutic Target in the Aging Brain
- PMID: 31376067
- PMCID: PMC6694322
- DOI: 10.1007/s13311-019-00769-6
Sleep as a Therapeutic Target in the Aging Brain
Abstract
Sleep is a behavioral phenomenon conserved among mammals and some invertebrates, yet the biological functions of sleep are still being elucidated. In humans, sleep time becomes shorter, more fragmented, and of poorer quality with advancing age. Epidemiologically, the development of age-related neurodegenerative diseases such as Alzheimer's and Parkinson's disease is associated with pronounced sleep disruption, whereas emerging mechanistic studies suggest that sleep disruption may be causally linked to neurodegenerative pathology, suggesting that sleep may represent a key therapeutic target in the prevention of these conditions. In this review, we discuss the physiology of sleep, the pathophysiology of neurodegenerative disease, and the current literature supporting the relationship between sleep, aging, and neurodegenerative disease.
Keywords: Alzheimer’s disease; Sleep; aging; cognitive decline; dementia; treatment..
Conflict of interest statement
This study was not industry-supported and the authors declare that they have no financial conflicts of interest.
Similar articles
-
Resistance, vulnerability and resilience: A review of the cognitive cerebellum in aging and neurodegenerative diseases.Neurobiol Learn Mem. 2020 Apr;170:106981. doi: 10.1016/j.nlm.2019.01.004. Epub 2019 Jan 7. Neurobiol Learn Mem. 2020. PMID: 30630042 Free PMC article. Review.
-
Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease?Trends Neurosci. 2016 Aug;39(8):552-566. doi: 10.1016/j.tins.2016.05.002. Epub 2016 Jun 17. Trends Neurosci. 2016. PMID: 27325209 Free PMC article. Review.
-
[Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].Glas Srp Akad Nauka Med. 2011;(51):85-97. Glas Srp Akad Nauka Med. 2011. PMID: 22165729 Review. Serbian.
-
Potential therapeutic target for aging and age-related neurodegenerative diseases: the role of acid sphingomyelinase.Exp Mol Med. 2020 Mar;52(3):380-389. doi: 10.1038/s12276-020-0399-8. Epub 2020 Mar 13. Exp Mol Med. 2020. PMID: 32203096 Free PMC article. Review.
-
Sleep in aging and neurodegenerative diseases.Suppl Clin Neurophysiol. 2004;57:508-20. doi: 10.1016/s1567-424x(09)70390-3. Suppl Clin Neurophysiol. 2004. PMID: 16106652 Review. No abstract available.
Cited by
-
Sleep-dependent memory consolidation in young and aged brains.Aging Brain. 2024 Sep 12;6:100124. doi: 10.1016/j.nbas.2024.100124. eCollection 2024. Aging Brain. 2024. PMID: 39309405 Free PMC article.
-
The glymphatic system: implications for drugs for central nervous system diseases.Nat Rev Drug Discov. 2022 Oct;21(10):763-779. doi: 10.1038/s41573-022-00500-9. Epub 2022 Aug 10. Nat Rev Drug Discov. 2022. PMID: 35948785 Review.
-
Glymphatic system: an emerging therapeutic approach for neurological disorders.Front Mol Neurosci. 2023 Jul 6;16:1138769. doi: 10.3389/fnmol.2023.1138769. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37485040 Free PMC article. Review.
-
Pre-treatment subjective sleep quality as a predictive biomarker of tDCS effects in preclinical Alzheimer's disease patients: Secondary analysis of a randomised clinical trial.PLoS One. 2025 Jan 28;20(1):e0317700. doi: 10.1371/journal.pone.0317700. eCollection 2025. PLoS One. 2025. PMID: 39874376 Free PMC article. Clinical Trial.
-
The potential value of exosomes as adjuvants for novel biologic local anesthetics.Front Pharmacol. 2023 Jan 26;14:1112743. doi: 10.3389/fphar.2023.1112743. eCollection 2023. Front Pharmacol. 2023. PMID: 36778004 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical